Manchester Financial Inc Vertex Pharmaceuticals Inc Transaction History

Manchester Financial Inc

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 21, 2021	SELL	$187.49 - $221.1 $187 - $221	-1 Closed	0 $0
Q1 2021 May 03, 2021	SELL	$207.02 - $241.31 $207 - $241	-1 Reduced 50.0%	1 $0
Q4 2020 Jan 26, 2021	SELL	$207.01 - $276.09 $20,701 - $27,608	-100 Reduced 98.04%	2 $0
Q2 2020 Jul 13, 2020	BUY	$225.48 - $295.8 $22,998 - $30,171	102 New	102 $30,000

1,625

222M

1.35M

1.49M

Ticker VRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 256,691,008
Market Cap $125B
Description
Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...

Get notified when there are updates to the investment portfolio of Manchester Financial Inc, based on Form 13F filings with the SEC.

Stay updated on Manchester Financial Inc with notifications on news.